Search

Your search keyword '"Freedman, Mark S"' showing total 1,173 results

Search Constraints

Start Over You searched for: Author "Freedman, Mark S" Remove constraint Author: "Freedman, Mark S"
1,173 results on '"Freedman, Mark S"'

Search Results

1. Physical Activity Together for People With Multiple Sclerosis and Their Care Partners: Protocol for a Feasibility Randomized Controlled Trial of a Dyadic Intervention

2. A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study

7. Neurofilaments as biomarkers in neurological disorders — towards clinical application

17. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

18. Contributors

22. Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attack.

24. Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study

25. Health Canada drug approval process: a barrier to personalized care in multiple sclerosis

27. The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study

32. Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD.

33. Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.

34. Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

38. Relationship between Metformin, Monoacylglycerol Lipase Expression, Cognition and Emotion Recognition in People with Multiple Sclerosis and Comorbid Type II Diabetes

39. Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

43. Heightened Precautions for Imported Dogs Vaccinated with Potentially Ineffective Rabies Vaccine--United States, August 2021-April 2024

45. Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation

47. From progression to progress: The future of multiple sclerosis.

48. Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

49. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

50. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Catalog

Books, media, physical & digital resources